SnapGene

Chicago, United States Founded: 2012 • Age: 14 yrs Acquired By Graphpad
Tool for laboratory management

About SnapGene

SnapGene is a Healthcare company based in Chicago (United States) founded in 2012, and was acquired by Graphpad in August 2019. Tool for laboratory management. Its website snapgene.com draws about 196 thousand monthly visits. SnapGene offers products and services including SnapGene, SnapGene Viewer, and SnapGene Academy. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its legal entity is GSL Biotech LLC. Its competitors include Waters Corporation, Ovation and Labvantage; 1 of its 3 listed competitors has raised funding.

Company details

SnapGene has designed tools to plan, visualize, and document molecular biology procedures. The SnapGene software is used to document cloning constructs electronically, and the following technologies enable users to design Gene cloning experiments from end to end. In-Fusion Cloning method helps to create fusion genes, whereas Gibson Assembly allows design of DNA fragments with overlapping ends for non-enzymatic insertion, the software also provides tools in PCR and mutagenesis studies. Other products include visualization software called SnapGeneViewer that allows designing of primers and probes and SnapGene server which assists websites into generating better quality genetic maps, with enhanced features.

  • Headquarters Chicago, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website snapgene.com
  • Social LinkedIn X Facebook
  • Acquired by Graphpad (Aug 2019)
  • Legal Name Gsl Biotech Llc
Key Metrics
  • Latest Funding Round
    $750K (USD), Grant

    Apr 2012

  • Investors
    HHS

    & 1 more

  • Acquired by
    Graphpad

    (Aug 2019)

Products & Services of SnapGene

SnapGene offers a comprehensive portfolio of products and services, including SnapGene, SnapGene Viewer, and SnapGene Academy.

SnapGene
Bioinformatics Software

Tool for planning and simulating molecular biology procedures

SnapGene Viewer
Software Viewer

Free application to view and share molecular biology data

SnapGene Academy
Educational Resource

Online platform for tutorials on molecular biology techniques

Funding Insights of SnapGene

  • Total Rounds 1
  • Last Round Grant — $750,000
  • First Round $750,000

    (Apr 2012)

  • Investors Count 1

All 1 funding rounds of SnapGene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2012$750,000Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in SnapGene

SnapGene has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Graphpad.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Cloud-based data visualization and analysis tools are supplied to scientists.
1989graphpad.comSan Diego, United States
Premium access

Investor details for SnapGene

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of SnapGene

3 dated milestones of SnapGene across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded SnapGene is founded.
  2. Funding First funding round of $750K.
  3. Exit Acquired by Graphpad.

Competitors of SnapGene

SnapGene has 3 listed competitors in our database, 1 of them funded. They include Waters Corporation, Ovation and Labvantage.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
waters.com1958Milford, United States9,341
Provider of laboratory management system for researchers and clinicians
ovation.io2009Cambridge, United States$33.28M35
Cloud-based platform for laboratory data management and collaboration is provided.
labvantage.com1989Somerset, United States100
LIMS, Quality ELN and Business Intelligence solutions for laboratory
Premium access

Detailed competitors of SnapGene

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SnapGene

The website of SnapGene (snapgene.com) receives about 195.8K visits a month.

  • Monthly visits
    195.8K

    ▼ 12.8% vs previous month

Similar websites

Websites whose visitors overlap most with SnapGene. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
addgene.org
addgene.org
100%
#84,256–
syngene.com
syngene.com
74%
–
benchling.com
68%
1.4M#36,159View details
jingege.wang
jingege.wang
68%
#2,694,853–
cell.com
65%
5M#14,619View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for SnapGene

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as SnapGene (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Snapgene

Premium access

Complete news archive for SnapGene

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SnapGene

SnapGene was founded in 2012.

SnapGene is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

SnapGene has designed tools to plan, visualize, and document molecular biology procedures. The SnapGene software is used to document cloning constructs electronically, and the following technologies enable users to design Gene cloning experiments from end to end. In-Fusion Cloning method helps to create fusion genes, whereas Gibson Assembly allows design of DNA fragments with overlapping ends for non-enzymatic insertion, the software also provides tools in PCR and mutagenesis studies. Other products include visualization software called SnapGeneViewer that allows designing of primers and probes and SnapGene server which assists websites into generating better quality genetic maps, with enhanced features.

SnapGene's top competitors include Ovation, Waters Corporation and Labvantage.

SnapGene offers SnapGene, SnapGene Viewer, and SnapGene Academy.

SnapGene has 2 investors. Key investors include HHS, and Graphpad.

SnapGene operates through Gsl Biotech Llc.

Yes. SnapGene was acquired by Graphpad in August 2019.

The website of SnapGene receives about 196 thousand visits a month.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available